Peptide Cost Analysis
Peptide Drug Cost Analysis
Section titled “Peptide Drug Cost Analysis”Per-Dose Costs
Section titled “Per-Dose Costs”| Peptide | Dose | Cost/Dose | Frequency | Annual Cost |
|---|---|---|---|---|
| Semaglutide (Ozempic) | 1 mg | ~$300 | Weekly | ~$15,600 |
| Liraglutide (Victoza) | 1.8 mg | ~$45 | Daily | ~$16,400 |
| Insulin glargine | 20 units | ~$15 | Daily | ~$5,500 |
| Insulin lispro | 10 units | ~$10 | Per meal | ~$10,900 |
Biosimilar Savings
Section titled “Biosimilar Savings”| Originator | Biosimilar | Savings |
|---|---|---|
| Insulin glargine (Lantus) | Basaglar | ~30% |
| Insulin lispro (Humalog) | Admelog | ~25% |
Cost Drivers
Section titled “Cost Drivers”- Raw materials: Amino acids, reagents, solvents
- Manufacturing: SPPS labor, HPLC purification
- Quality control: Analytical testing
- Regulatory: Clinical trials, FDA approval
- Distribution: Cold chain, specialty pharmacy